| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $41K | +105.0% |
| R&D Expense | $66.4M | -19.2% |
| SG&A Expense | $28.1M | +34.0% |
| Operating Income | -$94.5M | +8.4% |
| Pre-tax Income | -$88.8M | +6.6% |
| Income Tax | -$681K | — |
| Net Income | -$88.1M | +7.3% |
| EPS (Basic) | -$1.00 | +25.4% |
| EPS (Diluted) | -$1.00 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.8M | +18.5% |
| Short-term Investments | $229.7M | +141.9% |
| Accounts Receivable | $1.2M | +124.1% |
| Current Assets | $278.2M | +102.7% |
| Total Assets | $279.9M | +100.9% |
| Current Liabilities | $15.0M | +43.3% |
| Long-term Debt | $34.3M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.5M | +15.4% |
| Capital Expenditures | $11K | — |
| Investing Cash Flow | -$132.5M | -366.7% |
| Financing Cash Flow | $206.8M | +1959.4% |
| Free Cash Flow | -$67.5M | — |
| +25.4% |
| Total Liabilities |
| $55.0M |
| +248.4% |
| Stockholders' Equity | $224.9M | +82.1% |